- Mylan launches generic version of Trilipix
- Teva, Mylan launch Viagra generics in Europe
- FDA gives tentative approval to Mylan's generic Crestor
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
PITTSBURGH — Mylan has launched a generic drug for treating thiamine deficiency, the company said Thursday.
The generic drug maker announced the launch of thiamine hydrochloride injection in the 100-mg-per-mL strength, packaged in 25-vial packs of 200-mg-per-2-mL multiple-dose vials.
The drug had sales of about $18.6 million during the 12-month period ended in March, according to IMS Health. Mylan said it would ship the drug immediately.